# 2026-05482: DEA Updates Who Can Sign for Ordering Schedule I and II Drugs

2026-05482, Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2026-03-20, effective 2026-03-20; PRIA reads it as touching household money (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2026-05482
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-05482
- Title: Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 13498
- Published: 2026-03-20
- Effective: 2026-03-20
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

DEA Updates Who Can Sign for Ordering Schedule I and II Drugs

## Summary

If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!

## Abstract

On September 30, 2019, the Drug Enforcement Administration (DEA) published the final rule, New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222). The final rule implemented a new single sheet format for DEA Form 222 and provided for a two-year transition period to switch from the triplicate form. This technical amendment corrects certain regulations erroneously not amended in the final rule which creates ambiguities. The amendment clarifies that a DEA Form 222 Power of Attorney may only be executed or revoked by a registrant, a partner of the registrant, or an officer of a registrant corporate entity. It resolves ambiguity over who may sign a DEA Form 222 and removes the obsolete transition provision for the triplicate version of DEA Form 222. These are conforming revisions that do not make any substantive changes to the regulations.

## Effects PRIA read

- Who Can Sign DEA Form 222: cost, low. If you order Schedule I or II controlled substances using DEA Form 222, only the registrant (if an individual), a partner (if a partnership), or an officer (if a corporation, corporate division, association, trust, or other entity) may execute or revoke a Power of Attorney and sign the DEA Form 222…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-05482 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/20/2026-05482/ordering-schedule-i-and-ii-controlled-substances-using-dea-form-222-technical-amendments)
- [2026-05482 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-20/pdf/2026-05482.pdf)

## Related
- [Previous: 2026-05463, Correcting Amendment Reinstating “Grandfather” Exceptions to Restrictions on Pr…](https://policyrisk.com/federal-register/2026-05463)
- [Next: 2026-05492, Retirement Security Rule: Definition of an Investment Advice Fiduciary: Notice…](https://policyrisk.com/federal-register/2026-05492)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-05482 (as of 2026-06-11).
